Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Research article

The comorbidity of increased arterial stiffness and microalbuminuria in a survey of middle-aged adults in China

Authors: Rujia Miao, Liuxin Wu, Ping Ni, Yue Zeng, Zhiheng Chen

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Background

Increased arterial stiffness (iAS) and microalbuminuria (MAU), which may occur simultaneously or separately in the general population and share similar risk factors, are markers of macro- and microvascular injuries. Our research investigated the comorbidity of iAS and MAU in the middle-aged population and examined the heterogeneous effects of metabolic risk factors on iAS and MAU.

Methods

We selected 11,911 individuals aged 45 to 60 years who underwent a health examination at the 3rd Xiangya Hospital between 2010 and 2014. Metabolic syndrome (MetS) was determined according to IDF/NHLBI/AHA-2009 criteria. Multinomial logistic regression was applied to evaluate the influence of MetS, components of MetS and clusters of MetS on the co-occurrence (MAU(+)/iAS(+)) or non-co-occurrence (MAU(+)/iAS(−) and MAU(−)/iAS(+)) of MAU and iAS.

Results

Reference group was MAU(−)/iAS(−). A positive effect of MetS on the presence of MAU(+)/iAS(−), MAU(−)/iAS(+), or MAU(+)/iAS(+) is listed in ascending order based on odds ratios (ORs = 2.11, 2.41, 4.61, respectively; P < 0.05). Compared with MAU(+)/iAS(−), Elevated blood pressure (BP) (OR = 1.62 vs. 4.83, P < 0.05), triglycerides(TG) (OR = 1.20 vs. 1.37, P < 0.05) were more strongly associated with MAU(−)/iAS(+), whereas fasting blood glucose (FBG) was less associated (OR = 1.37 vs. 1.31, P < 0.05). Decreased high-density lipoprotein cholesterol(HDL-c) (OR = 1.84, P < 0.01) and elevated waist circumference(WC) (OR = 1.28 P < 0.01) were the most strongly associated with MAU(+)/iAS(−). Compared with the individuals without MetS, individuals with the elevated BP, FBG, TG and decreased HDL-c cluster had the greatest likelihood of presenting a MAU(−)/iAS(+) (OR = 5.98, P < 0.01) and MAU(+)/iAS(+) (OR = 13.17, P < 0.01), these likelihood was even greater than the cluster with simultaneous alteration in all five MetS components (OR = 3.89 and 10.77, respectively, P < 0.01), which showed the most strongly association with MAU(+)/iAS(+) (OR = 5.22, P < 0.01).

Conclusion

Based on the heterogeneous influences of MetS-related risk factors on MAU and iAS, these influences could be selectively targeted to identify different types of vascular injuries.
Literature
1.
Pietri P, Vlachopoulos C, Vyssoulis G, Ioakeimidis N, Stefanadis C. Macro- and microvascular alterations in patients with metabolic syndrome: sugar makes the difference. Hypertens Res. 2014;37(5):452–6.CrossRefPubMed
2.
Abdelhafiz AH, Ahmed S, El Nahas M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol. 2011;119(Suppl 1):e6–10.CrossRefPubMed
3.
4.
Wen W, Luo R, Tang X, Tang L, Huang HX, Wen X, et al. Age-related progression of arterial stiffness and its elevated positive association with blood pressure in healthy people. Atherosclerosis. 2015;238(1):147–52.CrossRefPubMed
5.
Yun YW, Shin MH, Lee YH, Rhee JA, Choi JS. Arterial stiffness is associated with diabetic retinopathy in Korean type 2 diabetic patients. J Prev Med Public Health. 2011;44(6):260–6.CrossRefPubMedPubMedCentral
6.
de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17(8):2100–5.CrossRefPubMed
7.
8.
Shin DI, Seung KB, Yoon HE, Hwang BH, Seo SM, Shin SJ, et al. Microalbuminuria is independently associated with arterial stiffness and vascular inflammation but not with carotid intima-media thickness in patients with newly diagnosed type 2 diabetes or essential hypertension. J Korean Med Sci. 2013;28(2):252–60.CrossRefPubMedPubMedCentral
9.
Seo JY, Kim MK, Choi BY, Kim YM, Cho SI, Shin J. Elevated brachial-ankle pulse wave velocity is independently associated with microalbuminuria in a rural population. J Korean Med Sci. 2014;29(7):941–9.CrossRefPubMedPubMedCentral
10.
Kim BJ, Lee HA, Kim NH, Kim MW, Kim BS, Kang JH. The association of albuminuria, arterial stiffness, and blood pressure status in nondiabetic, nonhypertensive individuals. J Hypertens. 2011;29(11):2091–8.CrossRefPubMed
11.
Munakata M, Miura Y, Yoshinaga K. Group JTs. Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: the J-TOPP study. J Hypertens. 2009;27(7):1466–71.CrossRefPubMed
12.
Scuteri A, Cunha PG, Rosei EA, Badariere J, Bekaert S, Cockcroft JR, et al. Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. Atherosclerosis. 2014;233(2):654–60.CrossRefPubMedPubMedCentral
13.
14.
Kuang DW, Li CL, Kuok UI, Cheung K, Lio WI, Xin J. Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao. BMC Nephrol. 2012;13:143.
15.
Chen F, Yang W, Weng J, Jia W, Ji L, Xiao J, et al. Albuminuria: prevalence, associated risk factors and relationship with cardiovascular disease. J Diabetes Investig. 2014;5(4):464–71.CrossRefPubMed
16.
Diaz A, Tringler M, Galli C, Ramirez A, Fischer EI. Arterial stiffness in a rural population of Argentina: pilot study. High Blood Press Cardiovasc Prev. 2015;22(4):403–9.CrossRefPubMed
17.
Zacharias JM, Young TK, Riediger ND, Roulette J, Bruce SG. Prevalence, risk factors and awareness of albuminuria on a Canadian first nation: a community-based screening study. BMC Public Health. 2012;12:290.
18.
Jang SY, Ju EY, Huh EH, Kim JH, Kim DK. Determinants of brachial-ankle pulse wave velocity and carotid-femoral pulse wave velocity in healthy Koreans. J Korean Med Sci. 2014;29(6):798–804.CrossRefPubMedPubMedCentral
19.
Xu L, Jiang CQ, Lam TH, Cheng KK, Yue XJ, Lin JM, et al. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou biobank cohort study-CVD. Metabolism. 2010;59(3):367–72.CrossRefPubMed
20.
Munakata M, Konno S, Ohshima M, Ikeda T, Miura Y, Ito S. High-normal blood pressure is associated with microalbuminuria in the general population: the Watari study. Hypertens Res. 2011;34(10):1135–40.CrossRefPubMed
21.
Rim JH, Lee YH, Cha BS, Lee SG, Kim JH. Central obesity is an independent risk factor for microalbuminuria in both the general Korean women and nondiabetic nonhypertensive subpopulation: association of microalbuminuria and metabolic syndrome from the Korea National Health and nutrition examination survey 2011-2012. Clin Chim Acta. 2015;448:74–9.
22.
Mikhed Y, Daiber A, Steven S. Mitochondrial oxidative stress, mitochondrial DNA damage and their role in age-related vascular dysfunction. Int J Mol Sci. 2015;16(7):15918–53.CrossRefPubMedPubMedCentral
23.
Organization WH. Measuring obesity – classification and description of anthropometric data: report on a WHO consultation on the epidemiology of obesity. Warsaw. 1987:2.
24.
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research. Circulation. 2005;111(5):697–716.CrossRefPubMed
25.
Levey ASGT, Kusek JW, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:828.
26.
van der Tol A, Van Biesen W, Van Laecke S, Bogaerts K, De Lombaert K, Warrinnier H, et al. Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study. PLoS One. 2012;7(2):e31639.CrossRefPubMedPubMedCentral
27.
Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects. Atherosclerosis. 2003;166(2):303–9.CrossRefPubMed
28.
Wang A, Tao J, Guo X, Liu X, Luo Y, Liu X, et al. The product of resting heart rate times blood pressure is associated with high brachial-ankle pulse wave velocity. PLoS One. 2014;9(9):e107852.CrossRefPubMedPubMedCentral
29.
Sakuragi S, Abhayaratna WP. Arterial stiffness: methods of measurement, physiologic determinants and prediction of cardiovascular outcomes. Int J Cardiol. 2010;138(2):112–8.CrossRefPubMed
30.
31.
Anvari MS, Boroumand MA, Pourgholi L, Sheikhfathollahi M, Rouhzendeh M, Rabbani S, et al. Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res. 2009;40(5):399–405.CrossRefPubMed
32.
Vyssoulis G, Karpanou E, Spanos P, Kyvelou SM, Adamopoulos D, Stefanadis C. Urine albumin excretion, within normal range, reflects increasing prevalence of metabolic syndrome in patients with essential hypertension. J Clin Hypertens (Greenwich). 2010;12(8):597–602.CrossRef
33.
Li CI, Kardia SL, Liu CS, Lin WY, Lin CH, Lee YD, et al. Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based Taichung community health study. BMC Public Health. 2011;11:808.
34.
Wang F, Chen HZ, Lv X, Liu DP. SIRT1 as a novel potential treatment target for vascular aging and age-related vascular diseases. Curr Mol Med. 2013;13(1):155–64.CrossRefPubMed
35.
Biggeri A, Stanghellini E, Ruggeri M. Regression analysis of multiple outcomes. Epidemiol Prev. 2001;25(2):83–9.PubMed
36.
Nikolopoulou A, Kadoglou NP. Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther. 2012;10(7):933–9.CrossRefPubMed
37.
Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, Pucci L, et al. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension. 2008;51(2):440–5.CrossRefPubMed
38.
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–74.CrossRefPubMed
39.
Weng C, Yuan H, Yang K, Tang X, Huang Z, Huang L, et al. Gender-specific association between the metabolic syndrome and arterial stiffness in 8,300 subjects. Am J Med Sci. 2013;346(4):289–94.CrossRefPubMed
40.
Dangardt F, Osika W, Volkmann R, Gan LM, Friberg P. Obese children show increased intimal wall thickness and decreased pulse wave velocity. Clin Physiol Funct Imaging. 2008;28(5):287–93.CrossRefPubMed
41.
Lurbe E, Torro I, Garcia-Vicent C, Alvarez J, Fernandez-Fornoso JA, Redon J. Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension. 2012;60(2):550–5.CrossRefPubMed
42.
Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38(3):429–33.CrossRefPubMed
43.
Corden B, Keenan NG, de Marvao AS, Dawes TJ, Decesare A, Diamond T, et al. Body fat is associated with reduced aortic stiffness until middle age. Hypertension. 2013;61(6):1322–7.CrossRefPubMed
44.
Mozos I, Luca CT. Crosstalk between oxidative and Nitrosative stress and arterial stiffness. Curr Vasc Pharmacol. 2017;15(5):446–56.CrossRefPubMed
45.
Joyce T, Chirino YI, Natalia MT, Jose PC. Renal damage in the metabolic syndrome (MetSx): disorders implicated. Eur J Pharmacol. 2018;818:554–68.
46.
Mozos I, Malainer C, Horbanczuk J, Gug C, Stoian D, Luca CT, et al. Inflammatory markers for arterial stiffness in cardiovascular diseases. Front Immunol. 2017;8(1058)
47.
Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, et al. Microvascular permeability in diabetes and insulin resistance. Microcirculation. 2007;14(4–5):363–73.CrossRefPubMed
48.
Piwkowska A. Role of protein kinase G and reactive oxygen species in the regulation of podocyte function in health and disease. J Cell Physiol. 2017;232(4):691–7.CrossRefPubMed
49.
Wang CH, Chang RW, Ko YH, Tsai PR, Wang SS, Chen YS, et al. Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde. PLoS One. 2014;9(3):e90471.CrossRefPubMedPubMedCentral
50.
51.
Scuteri A, Najjar SS, Orru M, Usala G, Piras MG, Ferrucci L, et al. The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA study. Eur Heart J. 2010;31(5):602–13.CrossRefPubMed
52.
Meyer ML, Tanaka H, Palta P, Cheng S, Gouskova N, Aguilar D, et al. Correlates of segmental pulse wave velocity in older adults: the atherosclerosis risk in communities (ARIC) study. Am J Hypertens. 2016;29(1):114–22.CrossRefPubMed
53.
Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27(10):2022–7.CrossRefPubMed
54.
Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens. 2005;19(5):401–6.CrossRefPubMed
Metadata
Title
The comorbidity of increased arterial stiffness and microalbuminuria in a survey of middle-aged adults in China
Authors
Rujia Miao
Liuxin Wu
Ping Ni
Yue Zeng
Zhiheng Chen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0817-1

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue

Research article

The evaluation of the aortic annulus displacement during cardiac cycle using magnetic resonance imaging

Research article

Presentation and outcomes of indigenous Australians with peripheral artery disease

Research article

Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis

Research article

Protective effect of hydrogen-rich saline on pressure overload-induced cardiac hypertrophyin rats: possible role of JAK-STAT signaling

Research article

Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers

Research article

Impact of cardiac catheterization timing and contrast media dose on acute kidney injury after cardiac surgery

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits